Amneal Pharmaceuticals Inc Class A (AMRX)
EBITDA Margin
20.92%
TTM · Period ending:
AMRX EBITDA Margin
Latest reported20.92%period ending
Latest reported20.92%period ending
AMRX TTM EBITDA Margin (28.37% → 20.92%)
TTM ebitda margin
High-resolution chart · PNG
AMRX ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 20.9204% | |
| 20.8594% | |
| 20.004% | |
| 18.932% | |
| 20.466% | |
| 19.3856% | |
| 15.7401% | |
| 13.4427% | |
| 13.5296% | |
| 13.9236% | |
| 16.7011% | |
| 19.5764% | |
| 19.1304% | |
| 7.36% | |
| 6.7995% | |
| 6.0211% | |
| 5.4267% | |
| 18.0149% | |
| 19.1576% | |
| 19.8958% | |
| 19.005% | |
| 17.0408% | |
| 17.3451% | |
| 15.5704% | |
| 19.6786% | |
| 18.3201% | |
| 9.5426% | |
| 11.2792% | |
| 11.0478% | |
| -0.9722% | |
| 6.5329% | |
| 10.1548% | |
| 7.3527% | |
| 31.3788% | |
| 29.7751% | |
| 28.3691% |